share_log

Vivani Medical (NASDAQ:VANI) Stock Price Down 2.5%

Vivani Medical (NASDAQ:VANI) Stock Price Down 2.5%

Vivani Medical（纳斯达克股票代码：VANI）股价下跌2.5％
Defense World ·  2022/12/28 01:51

Vivani Medical, Inc. (NASDAQ:VANI – Get Rating) was down 2.5% on Tuesday . The stock traded as low as $0.86 and last traded at $0.91. Approximately 119,948 shares changed hands during mid-day trading, an increase of 4% from the average daily volume of 115,268 shares. The stock had previously closed at $0.93.

周二，Vivani Medical, Inc.（纳斯达克股票代码：VANI — 获取评级）下跌2.5％。该股的交易价格低至0.86美元，最后一次交易价格为0.91美元。在午盘交易中，约有119,948股易手，较平均每日交易量115,268股增长了4％。该股此前收于0.93美元。

Analyst Upgrades and Downgrades

分析师升级和降级

Separately, ThinkEquity started coverage on Vivani Medical in a report on Monday, December 5th. They issued a "buy" rating and a $7.00 price target for the company.

另外，ThinkeQuity在12月5日星期一的一份报告中开始报道Vivani Medical。他们为该公司发布了 “买入” 评级和7.00美元的目标价。

Get
获取
Vivani Medical
维瓦尼医疗
alerts:
警报：

Vivani Medical Stock Down 2.5 %

Vivani Medical 股票下跌 2.5 ％

The firm has a fifty day moving average price of $1.52.

该公司的五十天移动平均价格为1.52美元。

Institutional Investors Weigh In On Vivani Medical

机构投资者关注Vivani Medical

A number of institutional investors and hedge funds have recently modified their holdings of the company. State Street Corp acquired a new stake in shares of Vivani Medical during the third quarter worth about $63,000. Vanguard Group Inc. acquired a new stake in shares of Vivani Medical during the third quarter worth about $682,000. Prelude Capital Management LLC acquired a new stake in shares of Vivani Medical during the third quarter worth about $25,000. BlackRock Inc. acquired a new stake in shares of Vivani Medical during the third quarter worth about $734,000. Finally, Commonwealth Equity Services LLC acquired a new stake in shares of Vivani Medical during the third quarter worth about $822,000.
一些机构投资者和对冲基金最近修改了对该公司的持股。State Street Corp在第三季度收购了Vivani Medical的新股份，价值约63,000美元。Vanguard Group Inc.在第三季度收购了Vivani Medical的新股份，价值约68.2万美元。Prelude Capital Management LLC在第三季度收购了Vivani Medical的新股份，价值约25,000美元。贝莱德公司在第三季度收购了Vivani Medical的新股份，价值约73.4万美元。最后，联邦股票服务有限责任公司在第三季度收购了Vivani Medical的新股份，价值约82.2万美元。

Vivani Medical Company Profile

Vivani Medical 公司简介

(Get Rating)

（获取评分）

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.

Vivani Medical, Inc是一家临床阶段的公司，开发了各种植入物，用于治疗医疗需求未得到满足的慢性病。它致力于开发微型药物植入物产品组合，以提供最小的药物特征波动；以及用于为盲人提供有用的人工视觉的植入式视觉假体设备组合。

Featured Stories

精选故事

  • Get a free copy of the StockNews.com research report on Vivani Medical (VANI)
  • 3 Industrial Stocks to Help Build Your 2023 Watchlist
  • The Institutions Choose CarMax Over Carvana, Should You?
  • Heatmap in Trading: How to Learn What Market Depth Hides
  • Micron Technology Sees Chip Recovery by the End of 2023
  • Three Healthcare Penny Stocks to Watch In The New Year
  • 免费获取 StockNews.com 关于 Vivani Medical (VANI) 的研究报告
  • 3 只工业股将帮助您建立 2023 年关注名单
  • 机构选择 CarMax 而不是 Carvana，你应该吗？
  • 交易热图：如何了解市场深度隐藏了什么
  • 美光科技预计芯片将在2023年底之前复苏
  • 新年值得关注的三只医疗保健细价股

Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.

接收 Vivani Medical Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Vivani Medical及相关公司的最新新闻和分析师评级的简明每日摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发